Investor Relations Home

IRIDEX Corporation was founded in 1989 and is a worldwide leader in developing, manufacturing, and marketing innovative and versatile laser-based medical systems, delivery devices and consumable instrumentation for the ophthalmology market.

The Company was incorporated in California in February 1989 as IRIS Medical Instruments, Inc. In November 1995, we changed our name to IRIDEX Corporation and reincorporated in Delaware. Investors and others should note that we announce material financial information to our investors using SEC filings, press releases, our investor relations website, public conference calls and webcasts.  We use these channels as well as social media to communicate with investors, customers and the public about our company, our products and other issues.  It is possible that the information we post on social media channels could be deemed to be material information.  We encourage investors, our customers, and others interested in our company to review the information we post on our Facebook page ( and Twitter feed (
Stock Quote
IRIX (Common Stock)
ExchangeNASDAQ (US Dollar)
Change (%) Stock is Up 0.66 (8.96%)
Data as of 10/05/15 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
Recent NewsMore >>
09/08/15IRIDEX Broadens Global Glaucoma Outreach With Novel Eye Pressure Diagnostic Device
Icare's Tonometer for Monitoring Intra-Ocular Pressure Adds to Recurring Revenue Stream MOUNTAIN VIEW, Calif., Sept. 8, 2015 /PRNewswire/ -- IRIDEX Corporation (Nasdaq: IRIX) today announced that it has added a novel intra-ocular pressure (IOP) monitoring device called a tonometer to its suite of commercial products for the global glaucoma market. The new device comes to IRIDEX through a distribution agreement with Icare Finland Plc, a subsidiary of the Revenio Group Corporation, the creator ... 
Printer Friendly Version
08/06/15IRIDEX Reports 2015 Second Quarter, Six-Month Results
MOUNTAIN VIEW, Calif., Aug. 6, 2015 /PRNewswire/ -- IRIDEX Corporation (Nasdaq: IRIX) today reported financial results for the second quarter and six months ended July 4, 2015.  Revenues were $9.0 million in the second quarter of 2015 compared to $10.6 million in the 2014 second quarter.  For the first six months of 2015, revenues were $19.8 million compared to $20.9 million in the prior year period. Gross margin for the 2015 second quarter was 46.7% compared to 50.0% in t... 
Printer Friendly Version
08/04/15IRIDEX Chief Financial Officer Resigns to Accept Another Opportunity
MOUNTAIN VIEW, Calif., Aug. 4, 2015 /PRNewswire/ -- IRIDEX Corporation (Nasdaq:IRIX) today announced that James H. Mackaness, who had served as chief financial officer since 2008 and as chief operating officer since 2012, has resigned his positions with the Company, effective August 21, 2015, to accept the chief financial officer position at another company. Mr. Mackaness intends to continue to serve in the CFO/COO role through the Company's second quarter earnings announcement and 10-Q filing. ... 
Printer Friendly Version
07/30/15IRIDEX Announces Second Quarter 2015 Conference Call and Release Date
MOUNTAIN VIEW, Calif., July 30, 2015 /PRNewswire/ -- IRIDEX Corporation (NASDAQ: IRIX) today announced that it will release its second quarter 2015 financial results after the market closes on Thursday, August 6, 2015.  In conjunction with the release, the Company will host a conference call with the investment community at 5:00 p.m. Eastern Time on Thursday, August 6, 2015 to discuss the results of the quarter and other business developments. Interested parties may access the live con... 
Printer Friendly Version
Primary IR Contact
Jim Mackaness
Chief Financial Officer and Chief Operating Officer
Phone: 650-605-8716

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

logo aa0logo agslogo ascrslogo asrslogo esrs0logo euretina